SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041401
Filing Date
2023-08-10
Accepted
2023-08-10 16:31:44
Documents
66
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q apgn-20230630.htm   iXBRL 10-Q 3134738
2 EX-31.1 apgn-ex31_1.htm EX-31.1 33318
3 EX-31.2 apgn-ex31_2.htm EX-31.2 33329
4 EX-32.1 apgn-ex32_1.htm EX-32.1 14677
5 EX-32.2 apgn-ex32_2.htm EX-32.2 14690
  Complete submission text file 0000950170-23-041401.txt   10627652

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apgn-20230630_def.xml EX-101.DEF 342451
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apgn-20230630_pre.xml EX-101.PRE 416382
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apgn-20230630_lab.xml EX-101.LAB 543400
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apgn-20230630_cal.xml EX-101.CAL 42268
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apgn-20230630.xsd EX-101.SCH 74629
60 EXTRACTED XBRL INSTANCE DOCUMENT apgn-20230630_htm.xml XML 1844457
Mailing Address 900 INDUSTRIAL ROAD, SUITE C SAN CARLOS CA 94070
Business Address 900 INDUSTRIAL ROAD, SUITE C SAN CARLOS CA 94070 650.931.6236
Apexigen, Inc. (Filer) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39488 | Film No.: 231160087
SIC: 2834 Pharmaceutical Preparations